ProKidney Corp. (PROK) Revenue History
Annual and quarterly revenue from 2019 to present
PROK Revenue Over Time (2019–2025)
PROK Revenue Growth History
1 of 1 years with positive growth- FY2019 revenue growth
- N/A
- FY2020 revenue growth
- N/A
- FY2021 revenue growth
- N/A
- FY2022 revenue growth
- N/A
- FY2023 revenue growth
- N/A
- FY2024 revenue growth
- N/A
- FY2025 revenue growth
- +1075.0%
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $226K | -1.7% |
| Q4 2025 | $225K | +196.1% |
| Q3 2025 | $217K | — |
| Q2 2025 | $221K | — |
| Q1 2025 | $230K | — |
| Q4 2024 | $76K | — |
| Q3 2024 | $0 | — |
| Q2 2024 | $0 | — |
Multi-year avg. share of annual revenue by fiscal quarter
PROK Revenue Analysis (2019–2025)
Current Revenue & Growth
As of June 23, 2026, ProKidney Corp. (PROK) generated trailing twelve-month (TTM) revenue of $889,000, reflecting slight decline in growth of -1.7% year-over-year. The most recent quarter (Q1 2026) recorded $226,000 in revenue, up 0.4% sequentially.
Historical Growth Trajectory
PROK's historical revenue data shows various trends over time. ProKidney Corp.'s highest annual revenue of $893,000 was recorded in 2025, an all-time high.
Peer Comparison
Compared to Healthcare sector peers — including FATE (-52.6% YoY), NTLA (+45.0% YoY), and BEAM (+108.0% YoY) — PROK has underperformed the peer group in revenue growth. Compare PROK vs FATE →
PROK Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| PROKCurrent | $889,000 | -1.7% | - | -18477.8% | |
 FATE | $7M | -52.6% | -26.7% | -2222.4% | |
 NTLA | $68M | +45.0% | +3.1% | -651.7% | |
 BEAM | $140M | +108.0% | +466.3% | -274.6% | |
 RGEN | $738M | +17.4% | +15.0% | 8.1% |
PROK Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $893K | +1075.0% | $893K | 100.0% | $-165,007,000 | -18477.8% |
| 2024 | $76K | - | $76K | 100.0% | $-183,676,000 | -241678.9% |
| 2023 | $0 | - | $0 | - | $-151,522,000 | - |
| 2022 | $0 | - | $0 | - | $-153,007,000 | - |
| 2021 | $0 | - | $0 | - | $-55,110,000 | - |
| 2020 | $0 | - | $0 | - | $-27,024,000 | - |
| 2019 | $0 | - | $0 | - | $-79,380,000 | - |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
7+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
PROK — Frequently Asked Questions
Quick answers to the most common questions about buying PROK stock.
Is PROK's revenue growth accelerating or slowing?
PROK revenue growth is slowing. TTM revenue is $889000.00, up -1.7% year-over-year — below the 5-year CAGR of N/A. The deceleration suggests maturing end-markets or increased competition.
What is PROK's revenue history from 2019 to 2026?
ProKidney Corp. (PROK) revenue history spans 2019 to 2026. TTM revenue as of 2026 is $889000.00, growing at -1.7% YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is PROK's long-term revenue growth rate (CAGR)?
ProKidney Corp.'s 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of -1.7% is below this long-term average. CAGR is the most reliable measure of sustained revenue momentum for PROK.
Why does PROK's quarterly revenue fluctuate?
PROK quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. ProKidney Corp.'s revenue data from 2019 to 2026 shows full historical quarterly detail on this page.
How is PROK's revenue distributed by segment?
PROK reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does PROK's revenue compare to industry peers?
ProKidney Corp. (PROK) with TTM revenue of $889000.00 and -1.7% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.